Healius Limited (HLS.AX)
ASX · AUD · Healthcare · Diagnostics & Research
A$0.455 (+3.41%) as of
Key statistics
- Market cap
- 330.41M
- Forward P/E
- -133.82
- EPS (TTM)
- -0.5700
- Dividend yield
- 0.00%
- 52-week range
- 0.3000 – 1.0700
- Beta
- 0.28
- Revenue (TTM)
- 1.37B
- Profit margin
- -30.27%
- Analyst target
- A$0.54983
- Volume
- 1.41M
About Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Sydney, NSW, Australia
- Employees
- 3,343
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.